BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24332539)

  • 1. Vav1 as a central regulator of invadopodia assembly.
    Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA
    Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.
    Razidlo GL; Wang Y; Chen J; Krueger EW; Billadeau DD; McNiven MA
    Dev Cell; 2013 Mar; 24(6):573-85. PubMed ID: 23537630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of Vav1 adaptor region reveals a new oncogenic activation.
    Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N
    Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
    Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ
    Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.
    Goicoechea SM; GarcĂ­a-Mata R; Staub J; Valdivia A; Sharek L; McCulloch CG; Hwang RF; Urrutia R; Yeh JJ; Kim HJ; Otey CA
    Oncogene; 2014 Mar; 33(10):1265-73. PubMed ID: 23524582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
    Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA
    Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways.
    Groysman M; Hornstein I; Alcover A; Katzav S
    J Biol Chem; 2002 Dec; 277(51):50121-30. PubMed ID: 12386169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta3 tyrosine phosphorylation and alphavbeta3-mediated adhesion are required for Vav1 association and Rho activation in leukocytes.
    Gao C; Schaefer E; Lakkis M; Blystone SD
    J Biol Chem; 2005 Apr; 280(15):15422-9. PubMed ID: 15699036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
    Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
    J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARHGAP17 regulates the spatiotemporal activity of Cdc42 at invadopodia.
    Kreider-Letterman G; Castillo A; Mahlandt EK; Goedhart J; Rabino A; Goicoechea S; Garcia-Mata R
    J Cell Biol; 2023 Feb; 222(2):. PubMed ID: 36571786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.
    Pichot CS; Arvanitis C; Hartig SM; Jensen SA; Bechill J; Marzouk S; Yu J; Frost JA; Corey SJ
    Cancer Res; 2010 Nov; 70(21):8347-56. PubMed ID: 20940394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase is not required for Src-induced formation of invadopodia in KM12C colon cancer cells and can interfere with their assembly.
    Vitale S; Avizienyte E; Brunton VG; Frame MC
    Eur J Cell Biol; 2008 Sep; 87(8-9):569-79. PubMed ID: 18562041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
    Liu BP; Burridge K
    Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
    Lazer G; Pe'er L; Farago M; Machida K; Mayer BJ; Katzav S
    J Biol Chem; 2010 Jul; 285(30):23075-85. PubMed ID: 20457609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An SH2 domain-dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizing guanine nucleotide-exchange factor action.
    Mahajan NP; Earp HS
    J Biol Chem; 2003 Oct; 278(43):42596-603. PubMed ID: 12920122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts.
    Sakai H; Chen Y; Itokawa T; Yu KP; Zhu ML; Insogna K
    Bone; 2006 Dec; 39(6):1290-301. PubMed ID: 16950670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdc42-interacting protein 4 is a Src substrate that regulates invadopodia and invasiveness of breast tumors by promoting MT1-MMP endocytosis.
    Hu J; Mukhopadhyay A; Truesdell P; Chander H; Mukhopadhyay UK; Mak AS; Craig AW
    J Cell Sci; 2011 May; 124(Pt 10):1739-51. PubMed ID: 21525036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
    Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
    Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.
    Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y
    Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanine exchange-dependent and -independent effects of Vav1 on integrin-induced T cell spreading.
    del Pozo MA; Schwartz MA; Hu J; Kiosses WB; Altman A; Villalba M
    J Immunol; 2003 Jan; 170(1):41-7. PubMed ID: 12496381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.